WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD 5.16
-0.09 (-1.71%)
Nov 3, 2025, 4:00 PM EST
WELL Health Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 1,120 | 919.69 | 776.05 | 569.14 | 302.32 | 50.24 | Upgrade | |
Revenue Growth (YoY) | 26.31% | 18.51% | 36.36% | 88.25% | 501.76% | 53.12% | Upgrade |
Cost of Revenue | 666.17 | 556.68 | 403.79 | 265.85 | 148.63 | 29.03 | Upgrade |
Gross Profit | 453.54 | 363.01 | 372.27 | 303.29 | 153.7 | 21.22 | Upgrade |
Selling, General & Admin | 334.97 | 285.76 | 250.82 | 190.52 | 92.52 | 24.13 | Upgrade |
Operating Expenses | 431.66 | 373.34 | 337.75 | 270.21 | 152.24 | 28.73 | Upgrade |
Operating Income | 21.87 | -10.33 | 34.52 | 33.08 | 1.46 | -7.51 | Upgrade |
Interest Expense | -42.7 | -37.62 | -33.6 | -25.29 | -9.01 | -1.94 | Upgrade |
Interest & Investment Income | 1.74 | 1.27 | 0.76 | 0.65 | 0.56 | 0.45 | Upgrade |
Earnings From Equity Investments | -5.95 | -4.34 | -0.38 | -0.4 | -0.21 | -0.59 | Upgrade |
Currency Exchange Gain (Loss) | 1.41 | 0.57 | 0.64 | -0.67 | -4.75 | -0.2 | Upgrade |
Other Non Operating Income (Expenses) | -23.4 | -25.97 | -5.16 | -2 | 1.55 | 0.34 | Upgrade |
EBT Excluding Unusual Items | -47.03 | -76.42 | -3.22 | 5.37 | -10.41 | -9.43 | Upgrade |
Merger & Restructuring Charges | 1.13 | - | - | -2.49 | -9.99 | -3.22 | Upgrade |
Gain (Loss) on Sale of Investments | -51.28 | 101.48 | 42.56 | 0.28 | - | 6.91 | Upgrade |
Gain (Loss) on Sale of Assets | 0.56 | 11.82 | 1.57 | 5.21 | - | - | Upgrade |
Legal Settlements | -16.55 | -20.44 | - | - | - | - | Upgrade |
Other Unusual Items | -8.55 | -7.46 | -21.41 | 9.16 | -5.09 | -1.86 | Upgrade |
Pretax Income | -121.73 | 8.99 | 19.5 | 17.53 | -25.49 | -7.61 | Upgrade |
Income Tax Expense | -6.58 | -20.1 | 2.86 | -1.15 | 5.8 | -4.36 | Upgrade |
Earnings From Continuing Operations | -115.15 | 29.1 | 16.64 | 18.68 | -31.29 | -3.25 | Upgrade |
Net Income to Company | -115.15 | 29.1 | 16.64 | 18.68 | -31.29 | -3.25 | Upgrade |
Minority Interest in Earnings | -1.35 | 3.51 | -16.56 | -17.31 | -12.89 | -0.48 | Upgrade |
Net Income | -116.5 | 32.61 | 0.08 | 1.37 | -44.18 | -3.72 | Upgrade |
Net Income to Common | -116.5 | 32.61 | 0.08 | 1.37 | -44.18 | -3.72 | Upgrade |
Net Income Growth | - | 39667.07% | -94.01% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 250 | 247 | 237 | 221 | 191 | 134 | Upgrade |
Shares Outstanding (Diluted) | 250 | 255 | 237 | 221 | 191 | 134 | Upgrade |
Shares Change (YoY) | 1.47% | 7.66% | 7.18% | 15.61% | 42.56% | 38.17% | Upgrade |
EPS (Basic) | -0.47 | 0.13 | 0.00 | 0.01 | -0.23 | -0.03 | Upgrade |
EPS (Diluted) | -0.47 | 0.13 | 0.00 | 0.01 | -0.23 | -0.03 | Upgrade |
EPS Growth | - | 37471.96% | -94.42% | - | - | - | Upgrade |
Free Cash Flow | 45.27 | -17 | 41.05 | 69.93 | -30.21 | -6.52 | Upgrade |
Free Cash Flow Per Share | 0.18 | -0.07 | 0.17 | 0.32 | -0.16 | -0.05 | Upgrade |
Gross Margin | 40.51% | 39.47% | 47.97% | 53.29% | 50.84% | 42.23% | Upgrade |
Operating Margin | 1.95% | -1.12% | 4.45% | 5.81% | 0.48% | -14.95% | Upgrade |
Profit Margin | -10.40% | 3.55% | 0.01% | 0.24% | -14.61% | -7.41% | Upgrade |
Free Cash Flow Margin | 4.04% | -1.85% | 5.29% | 12.29% | -9.99% | -12.97% | Upgrade |
EBITDA | 88.93 | 45.65 | 84.74 | 80.22 | 35.27 | -4.76 | Upgrade |
EBITDA Margin | 7.94% | 4.96% | 10.92% | 14.09% | 11.67% | -9.48% | Upgrade |
D&A For EBITDA | 67.05 | 55.98 | 50.22 | 47.13 | 33.81 | 2.75 | Upgrade |
EBIT | 21.87 | -10.33 | 34.52 | 33.08 | 1.46 | -7.51 | Upgrade |
EBIT Margin | 1.95% | -1.12% | 4.45% | 5.81% | 0.48% | -14.95% | Upgrade |
Effective Tax Rate | - | - | 14.67% | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.